| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHINTE.158.17.1933 |
| P698 | PubMed publication ID | 9759691 |
| P2093 | author name string | Cirillo M | |
| De Santo NG | |||
| Stamler R | |||
| Stamler J | |||
| Alfieri R | |||
| Laurenzi M | |||
| Panarelli W | |||
| Senigalliesi L | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1933-1939 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. | |
| P478 | volume | 158 |
| Q35118296 | +Microalbuminuria in hypertension |
| Q41216487 | A multicenter cohort study of primary hypertension in Korea: study design and interim analysis of the Korean registry of target organ damage in hypertension (KorHR). |
| Q46888031 | Abdominal obesity, systolic blood pressure, and microalbuminuria in normotensive and euglycemic Korean men. |
| Q37072213 | Adverse renal consequences of obesity |
| Q36736656 | Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients |
| Q35210216 | Albuminuria and racial disparities in the risk for ESRD. |
| Q44845293 | Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy |
| Q36088870 | Albuminuria, renal dysfunction and circadian blood pressure rhythm in older men: a population-based longitudinal cohort study |
| Q46078257 | Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study |
| Q37042326 | Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents |
| Q37473326 | Blood pressure, atherosclerosis, and albuminuria in 10,113 participants in the atherosclerosis risk in communities study |
| Q35176802 | Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance |
| Q36359500 | Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension |
| Q33736046 | Cohort profile: The Gubbio Population Study |
| Q38879739 | Cumulative Exposure to Systolic Blood Pressure During Young Adulthood Through Midlife and the Urine Albumin-to-Creatinine Ratio at Midlife |
| Q33776176 | Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials |
| Q51483508 | Effects of anthropometric measurements on renal function. |
| Q37004632 | Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin |
| Q45161371 | Evaluation of measures of urinary albumin excretion in epidemiologic studies. |
| Q33616629 | Genome-wide linkage analysis of pulse pressure in American Indians: the Strong Heart Study |
| Q35974034 | Hypertension and microalbuminuria: the new detrimental duo. |
| Q51307957 | Impact of glucose load in an oral glucose tolerance test on urinary albumin excretion varies with 2-h glucose levels. |
| Q36264790 | Incidence of microalbuminuria in tobacco chewers |
| Q39482428 | Inconsistency in albuminuria predictors in type 2 diabetes: a comparison between neural network and conditional logistic regression |
| Q83987062 | Increases in urinary albumin and beta2-microglobulin are independently associated with blood pressure in the Japanese general population: the Takahata Study |
| Q37235631 | Intra-abdominal fat and elevated urine albumin excretion in men with type 1 diabetes |
| Q36158522 | Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure? |
| Q35576423 | Lifestyle risk factors and chronic kidney disease |
| Q36772445 | Lipoprotein metabolism in chronic renal insufficiency |
| Q51938413 | Low glomerular filtration in the population: prevalence, associated disorders, and awareness. |
| Q92862853 | Metabolically Healthy Obesity and Risk of Incident Chronic Kidney Disease in a Korean Cohort Study |
| Q44624006 | Microalbuminuria and Cardiovascular Events in Elderly Hypertensive patients without Previous Cardiovascular Complications |
| Q44064903 | Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men. |
| Q35293817 | Microalbuminuria in HIV infection |
| Q74188488 | Microalbuminuria in hypertensive nonproteinuric renal transplant recipients: influence of previous acute rejection episodes and sodium intake |
| Q46757948 | Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors |
| Q39571547 | Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity |
| Q50734499 | Microalbuminuria is determined by systolic and pulse pressure over a 12-year period and related to peripheral artery disease in normotensive and hypertensive subjects: the Three Areas Study in Greece (TAS-GR). |
| Q37260097 | Microalbuminuria measured by three different methods, blood pressure and cardiovascular risk factors in elderly Swedish males. |
| Q61965149 | Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes |
| Q34535592 | Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension |
| Q44111028 | Microalbuminuria, cardiovascular disease and risk factors in a nondiabetic/nonhypertensive population. The Nord-Trøndelag Health Study (HUNT, 1995-97), Norway |
| Q40506095 | Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: the EPIC-Norfolk population-based study |
| Q34706583 | Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease |
| Q52887018 | Non-proteinuric rather than proteinuric renal diseases are the leading cause of end-stage kidney disease. |
| Q22241459 | Obesity and Risk for Chronic Renal Failure |
| Q92741743 | Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1 |
| Q38206189 | Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys |
| Q36399698 | Obesity and the response to intensified diuretic treatment in decompensated heart failure: a DOSE trial substudy |
| Q35137813 | Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study. |
| Q35404652 | Predictors of incident albuminuria in the Framingham Offspring cohort |
| Q37041653 | Prevalence of microalbuminuria in hypertensive patients and its associated cardiovascular risk in clinical cardiology: Moroccan results of the global i-SEARCH survey - a sub-analysis of a survey with 21,050 patients in 26 countries worldwide. |
| Q94466102 | Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women |
| Q61965162 | Relation between albumin in the urine and electrocardiographic markers of myocardial ischemia in patients without diabetes mellitus |
| Q45247203 | Relation of nutrient intake to microalbuminuria in nondiabetic middle-aged men and women: International Population Study on Macronutrients and Blood Pressure (INTERMAP). |
| Q43919037 | Relation of urinary urea to blood pressure: interaction with urinary sodium |
| Q33971284 | Relationships of risk factors for pre-eclampsia with patterns of occurrence of isolated gestational proteinuria during normal term pregnancy |
| Q34505660 | Renal effects of low-level environmental cadmium exposure: 5-year follow-up of a subcohort from the Cadmibel study |
| Q81600859 | Renin-angiotensin system polymorphisms interact with blood pressure in the determination of microalbuminuria in the general population |
| Q36734467 | Smoking and chronic kidney disease in healthy populations |
| Q33630531 | Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCH. |
| Q45058818 | Sodium intake affects urinary albumin excretion especially in overweight subjects |
| Q39165618 | Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria. |
| Q36791768 | The Association Between Smoking Tobacco After a Diagnosis of Diabetes and the Prevalence of Diabetic Nephropathy in the Korean Male Population. |
| Q40271917 | The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. |
| Q38982413 | The impact of insulin resistance on the kidney and vasculature |
| Q37788947 | The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor |
| Q35168076 | The relationship of cigarette smoking to end-stage renal disease |
| Q35548313 | Urinary albumin excretion in healthy adults: a cross sectional study of 24-hour versus timed overnight samples and impact of GFR and other personal characteristics |
| Q45199349 | Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects |
| Q89637381 | Vascular, cardiac and renal target organ damage associated to arterial hypertension: which noninvasive tools for detection? |
| Q34803864 | [Hypertension and the kidney]. |
Search more.